Once-Daily Dosing of Aminoglycosides
OBJECTIVE: To review the pharmacodynamic rationale for once-daily dosing of aminoglycosides and to summarize thee results of comparative trials in animals and humans. DATA SOURCES: Published articles on the pharmacodynamics of aminoglycosides and those comparing the therapeutic efficacy and toxicity...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1994-01-01
|
| Series: | Canadian Journal of Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/1994/769217 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832566955532353536 |
|---|---|
| author | William A Craig |
| author_facet | William A Craig |
| author_sort | William A Craig |
| collection | DOAJ |
| description | OBJECTIVE: To review the pharmacodynamic rationale for once-daily dosing of aminoglycosides and to
summarize thee results of comparative trials in animals and humans.
DATA SOURCES: Published articles on the pharmacodynamics of aminoglycosides and those comparing the
therapeutic efficacy and toxicity of once-daily administration will more frequent closing regimens.
DATA SELECTION: Fourteen randomized studies in infected patients that compared the efficacy and toxicity
of once-daily aminoglycoside dosing with twice- or thrice-daily dosing regimens were available for review.
Ten studies comparing the efficacy and toxicity of different an1inoglycoside dosing regimens in animal
models were also reviewed .
DATA EXTRACTION: Frequency of clinical response, nephrotoxicity and ototoxicity with each dosing regimen
were compared graphically and by x2 for statistical significance (P<0.05).
DATA SYNTHESIS: Once-daily dosing was consistently less toxic than more frequent dosing in animals. When
human pharmacokinetics were simulated in animals, efficacy of once-daily dosing was similar or enhanced
over more frequent dosing regimens. Once-daily dosing in patients, compared with twice- or thrice-daily
administration, was statistically more effective in two studies, less nephrotoxic in six studies, and less
ototoxic in one study. Similar efficacy and toxicity were observed in all the oilier studies.
CONCLUSIONS: Once-daily dosing of aminoglycosides has the potential to enhance efficacy, reduce toxicity
and lower administration costs for this drug class. The once-daily dosing regimen deserves serious
consideration for routine use of the aminoglycosides. |
| format | Article |
| id | doaj-art-71465b1a8bec45dd8702e0aa11715bf8 |
| institution | Kabale University |
| issn | 1180-2332 |
| language | English |
| publishDate | 1994-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Infectious Diseases |
| spelling | doaj-art-71465b1a8bec45dd8702e0aa11715bf82025-02-03T01:02:42ZengWileyCanadian Journal of Infectious Diseases1180-23321994-01-015Suppl C28C33C10.1155/1994/769217Once-Daily Dosing of AminoglycosidesWilliam A CraigOBJECTIVE: To review the pharmacodynamic rationale for once-daily dosing of aminoglycosides and to summarize thee results of comparative trials in animals and humans. DATA SOURCES: Published articles on the pharmacodynamics of aminoglycosides and those comparing the therapeutic efficacy and toxicity of once-daily administration will more frequent closing regimens. DATA SELECTION: Fourteen randomized studies in infected patients that compared the efficacy and toxicity of once-daily aminoglycoside dosing with twice- or thrice-daily dosing regimens were available for review. Ten studies comparing the efficacy and toxicity of different an1inoglycoside dosing regimens in animal models were also reviewed . DATA EXTRACTION: Frequency of clinical response, nephrotoxicity and ototoxicity with each dosing regimen were compared graphically and by x2 for statistical significance (P<0.05). DATA SYNTHESIS: Once-daily dosing was consistently less toxic than more frequent dosing in animals. When human pharmacokinetics were simulated in animals, efficacy of once-daily dosing was similar or enhanced over more frequent dosing regimens. Once-daily dosing in patients, compared with twice- or thrice-daily administration, was statistically more effective in two studies, less nephrotoxic in six studies, and less ototoxic in one study. Similar efficacy and toxicity were observed in all the oilier studies. CONCLUSIONS: Once-daily dosing of aminoglycosides has the potential to enhance efficacy, reduce toxicity and lower administration costs for this drug class. The once-daily dosing regimen deserves serious consideration for routine use of the aminoglycosides.http://dx.doi.org/10.1155/1994/769217 |
| spellingShingle | William A Craig Once-Daily Dosing of Aminoglycosides Canadian Journal of Infectious Diseases |
| title | Once-Daily Dosing of Aminoglycosides |
| title_full | Once-Daily Dosing of Aminoglycosides |
| title_fullStr | Once-Daily Dosing of Aminoglycosides |
| title_full_unstemmed | Once-Daily Dosing of Aminoglycosides |
| title_short | Once-Daily Dosing of Aminoglycosides |
| title_sort | once daily dosing of aminoglycosides |
| url | http://dx.doi.org/10.1155/1994/769217 |
| work_keys_str_mv | AT williamacraig oncedailydosingofaminoglycosides |